Both in Biotechnology
Biogen vs Kymera Therapeutics
Over the past year BIIB returned +67.5% and KYMR returned +112.0%; their daily moves had a correlation of 0.16.
BIIB +67.5% KYMR +112.0%Growth of $1, one year, split-adjusted
| Metric | BIIB | KYMR |
|---|---|---|
| Price | $253.62 | $126.63 |
| Market cap | $37.49B | $10.81B |
| Today | +1.59% | +3.29% |
| 1 month | +13.8% | +15.0% |
| 6 months | +35.6% | +56.9% |
| Year to date | +44.1% | +62.7% |
| 1 year | +71.5% | +110.9% |
| Revenue growth (YoY) | +10.6% | −100.0% |
| Gross margin | 73.3% | — |
| Net margin | −0.7% | — |
| P/E (TTM) | 107.9× | — |
| Price / sales | 3.6× | 105.7× |
| Net cash | -$6.39B | $969.2M |
| Dividend yield | — | — |
| Volatility (60d) | 27.9% | 38.9% |
| Short % of float | 3.7% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).